相关实验视频
Updated: Jul 17, 2025
06:09
Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
7.0K
定义和促进儿童肺部健康:开发肺部健康的生物标志物
Michael D Davis1, Joe G Zein2, Silvia Carraro3
1Wells Center for Pediatric Research and Division of Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children at Indiana University, Indianapolis, Indiana.
Pediatrics
|September 1, 2023
概括
早期发现儿童肺部疾病至关重要. 基因测试和新型生物标志物的进展可以帮助在不可逆转的肺功能丧失发生之前识别和管理呼吸系统疾病.
科学领域:
- 儿科肺病学 儿科肺病学
- 生物标志物发现发现
- 呼吸系统医学 呼吸系统医学
背景情况:
- 儿童呼吸系统疾病可能导致成年后肺功能下降.
- 目前用于早期检测和疾病进展评估的方法不足.
- 进步为早期干预和预防肺损伤提供了潜力.
研究的目的:
- 总结国家心脏,肺和血液研究所关于开发儿童肺部健康生物标志物的研讨会的主要讨论.
- 突出儿童肺部疾病的识别和评估方面的进展.
- 强调早期检测和干预的重要性.
主要方法:
- 综述了2021年"定义和促进儿童肺部健康"研讨会的会议内容.
- 讨论基因测试的进展.
- 探索儿童肺部疾病的新型诊断工具和生物标志物.
主要成果:
- 基因评估正在改善疾病检测.
- 低成本的诊断和最小侵入性的生物标志物显示出有希望的结果.
- 呼出的氧化和新的生物标志物正在为儿童肺部疾病进行研究.
结论:
- 新的生物标志物和诊断工具可以帮助儿童呼吸系统疾病的早期检测和管理.
- 积极的识别和监测可以防止长期的肺功能下降.
- 对生物标志物的持续研究对于改善儿科肺部健康结果至关重要.
相关概念视频
01:25Pulmonary Function Tests
365
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
365
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
01:30Pneumonia III: Complications and Assessment
261
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
261